Successful Management of a Patient With Multiple Nucleos(t)ide Analogue-Resistant Hepatitis B Virus and Diffuse Large B Cell Lymphoma Using Tenofovir Disoproxil Fumarate: A Case Report

Journal of Nihon University Medical Association
doi 10.4264/numa.78.5_295
Full Text
Abstract

Available in full text

Date
Authors
Publisher

The Nihon University Medical Association

Related search

Tenofovir Plus Entecavir Combination Therapy for Chronic Hepatitis B With Nucleos(t)ide Analogue Failure

The European Research Journal
2020English

Efficacy and Safety of Tenofovir in a Kidney Transplant Patient With Chronic Hepatitis B and Nucleos(t)ide Multidrug Resistance: A Case Report

Journal of Medical Case Reports
Medicine
2014English

Monotherapy With Tenofovir Disoproxil Fumarate for Multiple Drug-Resistant Chronic Hepatitis B: 3-Year Trial

Hepatology
MedicineHepatology
2017English

Diffuse Large B-Cell Lymphoma: A Case Report

Clinical and Experimental Health Sciences
2018English

Primary Cutaneous Diffuse Large B-Cell Lymphoma – A Case Report

Serbian Journal of Dermatology and Venereology
Dermatology
2017English

Editorial: Tenofovir Disoproxil Fumarate and Prevention of Mother-To-Child Transmission of Hepatitis B Virus

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2019English

Dynamics of Hepatitis B Virus Quasispecies Heterogeneity in Association With Nucleos(t)ide Analogue Treatment Determined by MALDI-TOF MS

Clinical Microbiology and Infection
MedicineInfectious DiseasesMicrobiology
2015English

Diffuse Large B-Cell Lymphoma Presenting With Diabetes Insipidus: A Case Report

AACE Clinical Case Reports
2015English

Letter: Which Patients With Hepatitis B Virus-Related Hepatocellular Carcinoma Should Receive Nucleos(t)ide Analogue Therapy? Authors' Reply

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy